These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30953468)

  • 21. Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors.
    Gajjar A; Fouladi M; Walter AW; Thompson SJ; Reardon DA; Merchant TE; Jenkins JJ; Liu A; Boyett JM; Kun LE; Heideman RL
    J Clin Oncol; 1999 Jun; 17(6):1825-8. PubMed ID: 10561221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum alpha 2-HS glycoprotein predicts survival in patients with glioblastoma.
    Petrik V; Saadoun S; Loosemore A; Hobbs J; Opstad KS; Sheldon J; Tarelli E; Howe FA; Bell BA; Papadopoulos MC
    Clin Chem; 2008 Apr; 54(4):713-22. PubMed ID: 18281421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.
    Darlix A; Hirtz C; Thezenas S; Maceski A; Gabelle A; Lopez-Crapez E; De Forges H; Firmin N; Guiu S; Jacot W; Lehmann S
    BMC Cancer; 2019 Jan; 19(1):110. PubMed ID: 30700265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
    Li BT; Lou E; Hsu M; Yu HA; Naidoo J; Zauderer MG; Sima C; Johnson ML; Daras M; DeAngelis LM; Fleisher M; Kris MG; Azzoli CG
    PLoS One; 2016; 11(1):e0146063. PubMed ID: 26730601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The plant sterol brassicasterol as additional CSF biomarker in Alzheimer's disease.
    Vanmierlo T; Popp J; Kölsch H; Friedrichs S; Jessen F; Stoffel-Wagner B; Bertsch T; Hartmann T; Maier W; von Bergmann K; Steinbusch H; Mulder M; Lütjohann D
    Acta Psychiatr Scand; 2011 Sep; 124(3):184-92. PubMed ID: 21585343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.
    Feneberg E; Steinacker P; Volk AE; Weishaupt JH; Wollmer MA; Boxer A; Tumani H; Ludolph AC; Otto M
    J Neural Transm (Vienna); 2016 Mar; 123(3):289-96. PubMed ID: 26659729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients.
    Lemstra AW; van Meegen MT; Vreyling JP; Meijerink PH; Jansen GH; Bulk S; Baas F; van Gool WA
    Neurology; 2000 Aug; 55(4):514-6. PubMed ID: 10953182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in the immunobiochemical composition of the cerebrospinal fluid and the antitumor reactions of the local immune system in astrocytic brain tumors].
    Khil'ko VA; Khlunovskiĭ AN; Starchenko AA; Komarets SA; Lushnov MS
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(4):36-9. PubMed ID: 7856374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-6 Quotient (The Ratio of Cerebrospinal Fluid IL-6 to Serum IL-6) as a Biomarker of an Unruptured Intracranial Aneurysm.
    Kamińska J; Dymicka-Piekarska V; Chrzanowski R; Sawicki K; Milewska AJ; Zińczuk J; Tylicka M; Jadeszko M; Mariak Z; Kratz EM; Matowicka-Karna J; Kornhuber J; Lewczuk P; Koper-Lenkiewicz OM
    J Inflamm Res; 2021; 14():6103-6114. PubMed ID: 34848990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma.
    Zhi F; Wang Q; Xue L; Shao N; Wang R; Deng D; Wang S; Xia X; Yang Y
    PLoS One; 2015; 10(8):e0135242. PubMed ID: 26252651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil chemotaxis in cerebral astrocytoma.
    Kay NE; Murray KJ; Douglas SD
    Surg Neurol; 1977 Oct; 8(4):255-7. PubMed ID: 898000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer.
    Lee HS; Lee HE; Park DJ; Kim HH; Kim WH; Park KU
    Clin Chim Acta; 2012 Nov; 413(21-22):1753-60. PubMed ID: 22796372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic value of neuron specific enolase (NSE) in the cerebrospinal fluid of malignant brain tumor with intrathecal metastasis].
    Miyagami M; Tazoe M; Tsubokawa T
    No To Shinkei; 1989 Oct; 41(10):1021-7. PubMed ID: 2605041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human chorionic gonadotropin detection in cerebrospinal fluid of patients with a germinoma and its prognostic significance: assessment by using a highly sensitive enzyme immunoassay.
    Fukuoka K; Yanagisawa T; Suzuki T; Shirahata M; Adachi JI; Mishima K; Fujimaki T; Katakami H; Matsutani M; Nishikawa R
    J Neurosurg Pediatr; 2016 Nov; 18(5):573-577. PubMed ID: 27391806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evidence of new diagnostic and prognostic human astrocytoma tumor markers. Potential therapeutic applications. I].
    Salmon I
    Bull Mem Acad R Med Belg; 1998; 153(3):199-207. PubMed ID: 9760761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased levels of interleukin-10 and transforming growth factor-beta 2 in cerebrospinal fluid of patients with high grade astrocytoma.
    Krzyszkowski T; Dziedzic T; Czepko R; Szczudlik A
    Neurol Res; 2008 Apr; 30(3):294-6. PubMed ID: 17848206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.
    Nguyen-Them L; Costopoulos M; Tanguy ML; Houillier C; Choquet S; Benanni H; Elias-Shamieh R; Armand M; Faivre G; Glaisner S; Malak S; Vargaftig J; Hoang-Xuan K; Ahle G; Touitou V; Cassoux N; Davi F; Merle-Béral H; Le Garff-Tavernier M; Soussain C;
    Eur J Cancer; 2016 Jul; 61():69-76. PubMed ID: 27156226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased cerebrospinal fluid cleaved tau protein (C-tau) levels suggest axonal damage in pediatric patients with brain tumors.
    Cengiz P; Zemlan F; Eickhoff JC; Ellenbogen R; Zimmerman JJ
    Childs Nerv Syst; 2015 Aug; 31(8):1313-9. PubMed ID: 25899850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.
    Spreafico F; Bongarzone I; Pizzamiglio S; Magni R; Taverna E; De Bortoli M; Ciniselli CM; Barzanò E; Biassoni V; Luchini A; Liotta LA; Zhou W; Signore M; Verderio P; Massimino M
    Oncotarget; 2017 Jul; 8(28):46177-46190. PubMed ID: 28526811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.